Bank of New York Mellon Corp - AMNEAL PHARMACEUTICALS INC ownership

AMNEAL PHARMACEUTICALS INC's ticker is AMRX and the CUSIP is 03168L105. A total of 155 filers reported holding AMNEAL PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 1.00 and the average weighting 0.1%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of AMNEAL PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$2,904,888
+49.1%
688,362
+9.6%
0.00%
Q2 2023$1,947,848
+202.5%
628,338
+35.7%
0.00%
Q1 2023$643,849
-33.6%
463,201
-5.0%
0.00%
Q4 2022$969,852
-18.4%
487,363
-17.1%
0.00%
Q3 2022$1,188,000
-30.7%
587,856
+9.0%
0.00%
Q2 2022$1,715,000
-27.4%
539,330
-4.8%
0.00%
Q1 2022$2,361,000
-12.0%
566,337
+1.1%
0.00%
Q4 2021$2,684,000
-14.1%
560,240
-4.2%
0.00%
-100.0%
Q3 2021$3,123,000
+10.1%
584,843
+5.6%
0.00%0.0%
Q2 2021$2,836,000
-34.1%
553,748
-13.4%
0.00%0.0%
Q1 2021$4,304,000
+21.5%
639,543
-17.5%
0.00%0.0%
Q4 2020$3,541,000
-8.6%
774,820
-22.4%
0.00%0.0%
Q3 2020$3,873,000
-22.7%
998,046
-5.2%
0.00%0.0%
Q2 2020$5,011,000
+14.9%
1,052,772
-16.0%
0.00%0.0%
Q1 2020$4,360,000
-31.6%
1,253,009
-5.2%
0.00%
-50.0%
Q4 2019$6,374,000
+310.7%
1,322,416
+147.1%
0.00%
Q3 2019$1,552,000
-56.8%
535,250
+6.7%
0.00%
-100.0%
Q2 2019$3,595,000
-47.8%
501,408
+3.2%
0.00%
-50.0%
Q1 2019$6,887,000
+15.5%
485,973
+10.2%
0.00%0.0%
Q4 2018$5,964,000
-45.6%
440,799
-10.9%
0.00%
-33.3%
Q3 2018$10,973,000
+43.1%
494,535
+5.8%
0.00%
+50.0%
Q2 2018$7,668,000467,3290.00%
Other shareholders
AMNEAL PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Fosun International Ltd 21,521,301$83,503,0007.34%
Eversept Partners, LP 2,656,208$10,306,0872.29%
TPG Group Holdings (SBS) Advisors, Inc. 16,213,367$62,908,0001.13%
Prosight Management, LP 512,659$1,989,0000.95%
THB ASSET MANAGEMENT 833,104$3,232,0000.90%
GLOBEFLEX CAPITAL L P 251,696$977,0000.26%
XTX MARKETS LLC 10,243$40,0000.19%
HUSSMAN STRATEGIC ADVISORS, INC. 102,000$396,0000.10%
PA Capital LLC 33,874$132,0000.09%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 60,900$236,0000.07%
View complete list of AMNEAL PHARMACEUTICALS INC shareholders